Patheon N.V. Stock Price, News & Analysis (NYSE:PTHN)

$34.98 0.00 (0.00 %)
(As of 11/18/2017 03:58 AM ET)
Previous Close$34.98
Today's RangeN/A
52-Week Range$23.72 - $35.13
VolumeN/A
Average Volume754,718 shs
Market Capitalization$5.08 billion
P/E Ratio45.43
Dividend YieldN/A
BetaN/A

About Patheon N.V. (NYSE:PTHN)

Patheon N.V. logoPatheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company's segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products. The PDS segment provides a range of formulation, production and technical services from the early stages of a product's development to regulatory approval, as well as for new formulations of approved products for lifecycle extension. The DSS segment provides small molecule active pharmaceutical ingredient (API) and outsourced manufacturing solutions for large molecule biological API from early development through commercial scale production. It provides an integrated range of API and finished drug product services to its customers, from formulation development to clinical and commercial-scale manufacturing.


Industry, Sector and Symbol:
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Sector: Pharmaceuticals - NEC
  • Symbol: NYSE:PTHN
  • Previous Symbol: NASDAQ:PTHN
  • CUSIP: N/A
  • Web: www.patheon.com
Debt:
  • Debt-to-Equity Ratio: -7.33%
  • Current Ratio: 1.65%
  • Quick Ratio: 0.91%
Price-To-Earnings:
  • Trailing P/E Ratio: 45.43
Sales & Book Value:
  • Annual Sales: $1.8667 billion
  • Price / Sales: 2.72
  • Book Value: ($2.40) per share
  • Price / Book: -14.58
Profitability:
  • Trailing EPS: $0.76
  • Net Income: $31.7 million
  • Net Margins: 5.63%
  • Return on Equity: -35.93%
  • Return on Assets: 4.18%
Misc:
  • Employees: 9,100
  • Outstanding Shares: 145,140,000
 

Frequently Asked Questions for Patheon N.V. (NYSE:PTHN)

What is Patheon N.V.'s stock symbol?

Patheon N.V. trades on the New York Stock Exchange (NYSE) under the ticker symbol "PTHN."

How were Patheon N.V.'s earnings last quarter?

Patheon N.V. (NYSE:PTHN) posted its earnings results on Thursday, June, 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.19 by $0.01. The company earned $483.40 million during the quarter, compared to analysts' expectations of $466.08 million. Patheon N.V. had a net margin of 5.63% and a negative return on equity of 35.93%. The business's quarterly revenue was up 3.2% on a year-over-year basis. View Patheon N.V.'s Earnings History.

Where is Patheon N.V.'s stock going? Where will Patheon N.V.'s stock price be in 2017?

7 equities research analysts have issued twelve-month price targets for Patheon N.V.'s shares. Their predictions range from $28.00 to $35.00. On average, they expect Patheon N.V.'s stock price to reach $33.60 in the next year. View Analyst Ratings for Patheon N.V..

Who are some of Patheon N.V.'s key competitors?

Who are Patheon N.V.'s key executives?

Patheon N.V.'s management team includes the folowing people:

  • Paul S. Levy, Chairman of the Board
  • James C. Mullen, Chief Executive Officer, Director
  • Stuart R. Grant, Chief Financial Officer, Executive Vice President
  • Gilles A. Cottier, President - Global Pharmaceutical Development Services
  • Franco Negron, President - Drug Product Services
  • Lukas Utiger, President - Drug Substance
  • Michael J. Lehmann, Executive Vice President - Global Sales and Marketing
  • Michael E. Lytton J.D., Executive Vice President - Corporate Development and Strategy
  • Rebecca Holland New, Chief Human Resources Officer and Executive Vice President - Communications and Project Management Office
  • Harry R. Gill III, Senior Vice President - Quality and Continuous Improvement

When did Patheon N.V. IPO?

(PTHN) raised $625 million in an IPO on Thursday, July 21st 2016. The company issued 30,500,000 shares at a price of $19.00-$22.00 per share. J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank, Credit Suisse, Evercore ISI and Wells Fargo Securities acted as the underwriters for the IPO and Baird, Piper Jaffray, Raymond James, William Blair, KeyBanc Capital Markets and Leerink Partners were co-managers.

Who owns Patheon N.V. stock?

Patheon N.V.'s stock is owned by many different of retail and institutional investors. Top institutional investors include THERMO FISHER SCIENTIFIC INC. (99.00%). Company insiders that own Patheon N.V. stock include Jll Patheon Co-Investment Fund, Pamela Daley, Paul S Levy and Philip Eykerman. View Institutional Ownership Trends for Patheon N.V..

How do I buy Patheon N.V. stock?

Shares of Patheon N.V. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Patheon N.V.'s stock price today?

One share of Patheon N.V. stock can currently be purchased for approximately $34.98.

How big of a company is Patheon N.V.?

Patheon N.V. has a market capitalization of $5.08 billion and generates $1.8667 billion in revenue each year. The company earns $31.7 million in net income (profit) each year or $0.76 on an earnings per share basis. Patheon N.V. employs 9,100 workers across the globe.

How can I contact Patheon N.V.?

Patheon N.V.'s mailing address is Herengracht 483, AMSTERDAM, 1017 BT, Netherlands. The company can be reached via phone at +31-20-6223243.


MarketBeat Community Rating for Patheon N.V. (NYSE PTHN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  224
MarketBeat's community ratings are surveys of what our community members think about Patheon N.V. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Patheon N.V. (NYSE:PTHN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 6 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $33.60 (3.95% downside)

Consensus Price Target History for Patheon N.V. (NYSE:PTHN)

Price Target History for Patheon N.V. (NYSE:PTHN)

Analysts' Ratings History for Patheon N.V. (NYSE:PTHN)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Jefferies Group LLCReiterated RatingHold$35.00LowView Rating Details
6/9/2017Leerink SwannDowngradeOutperform -> Market Perform$31.00 -> $35.00LowView Rating Details
6/9/2017Raymond James Financial, Inc.DowngradeOutperform -> Mkt PerformLowView Rating Details
6/8/2017J P Morgan Chase & CoDowngradeOverweight -> NeutralLowView Rating Details
5/15/2017Evercore ISIDowngradeOutperform$35.00LowView Rating Details
5/15/2017William BlairDowngradeOutperform -> Market PerformLowView Rating Details
5/15/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralLowView Rating Details
3/17/2017Robert W. BairdDowngradeOutperform -> Neutral$34.00 -> $28.00LowView Rating Details
8/16/2016Credit Suisse GroupInitiated CoverageNeutral$30.00N/AView Rating Details
8/15/2016Wells Fargo & CompanyInitiated CoverageOutperformN/AView Rating Details
8/15/2016Morgan StanleyInitiated CoverageOverweight$31.00N/AView Rating Details
8/15/2016KeyCorpInitiated CoverageOverweight$33.00N/AView Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for Patheon N.V. (NYSE:PTHN)

Earnings by Quarter for Patheon N.V. (NYSE:PTHN)

Earnings History by Quarter for Patheon N.V. (NYSE PTHN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/8/20174/30/2017$0.19$0.20$466.08 million$483.40 millionViewN/AView Earnings Details
3/16/20171/31/2017$0.22$0.14$463.39 million$457.40 millionViewN/AView Earnings Details
12/20/2016Q416$0.39$0.30$496.27 million$510.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Patheon N.V. (NYSE:PTHN)
Current Year EPS Consensus Estimate: $1.03 EPS

Dividends

Dividend History for Patheon N.V. (NYSE:PTHN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Patheon N.V. (NYSE PTHN)

Insider Ownership Percentage: 0.14%
Institutional Ownership Percentage: 19.07%
Insider Trades by Quarter for Patheon N.V. (NYSE:PTHN)
Insider Trades by Quarter for Patheon N.V. (NYSE:PTHN)

Insider Trades by Quarter for Patheon N.V. (NYSE PTHN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2016Paul S LevyDirectorBuy10,000$29.55$295,500.00View SEC Filing  
9/28/2016Paul S LevyDirectorBuy15,000$29.64$444,600.00View SEC Filing  
9/12/2016Paul S LevyDirectorBuy37,000$28.01$1,036,370.00View SEC Filing  
7/26/2016Jll Patheon Co-Investment FundMajor ShareholderBuy815,730$19.85$16,192,240.50View SEC Filing  
7/26/2016Pamela DaleyDirectorBuy48,800$19.85$968,680.00View SEC Filing  
7/21/2016Philip EykermanDirectorBuy28,000$25.00$700,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Patheon N.V. (NYSE PTHN)

Source:
DateHeadline
Financial Review: Cambrex Corporation (CBM) versus Patheon N.V. (PTHN)Financial Review: Cambrex Corporation (CBM) versus Patheon N.V. (PTHN)
www.americanbankingnews.com - November 17 at 11:44 PM

Social Media

Financials

Financials are not available for this stock.

Chart

Patheon N.V. (NYSE PTHN) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.